These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Author: Di Blasi S, Pintacuda S, Ferotti N, Lo Coco L, Muratore A, Russo G, Di Blasi U, D'Alessandro M, Morici G, Fornaciari M.
    Journal: G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826.
    Abstract:
    Indobufen (200 mg b.i.d., by os, for 21 days) was gave to 16 patients with atherothrombotic risk in which platelet function was valued. In this subjects, indobufen significatively reduced platelet aggregation, beta-thromboglobulin, platelet factor the 4th and alpha-platelet granules' intake. No side effects were found.
    [Abstract] [Full Text] [Related] [New Search]